By Gregg T. Kokame, MD
    World Ophthalmology Congress 2012

    Dr. Gregg Kokame, clinical professor of ophthalmology at the University of Hawaii School of Medicine, discusses the benefits of Eylea (aflibercept) compared with other anti-VEGF drugs, as well as late-stage trials for diabetic macular edema and reports of sterile intraocular inflammation following Eylea injections.